Live Breaking News & Updates on சமூக மருத்துவமனை ஆண்டிமைக்ரோபியல் பணிப்பெண் முயற்சிகள்

Stay updated with breaking news from சமூக மருத்துவமனை ஆண்டிமைக்ரோபியல் பணிப்பெண் முயற்சிகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

COVID-19 monoclonal antibodies reduce risk of hospitalization and death


 E-Mail
IMAGE: Associate professor in Pitt s Division of Infectious Diseases and director of the UPMC Community Hospital Antimicrobial Stewardship Efforts (CHASE) Program.
view more 
Credit: UPMC
PITTSBURGH, May 17, 2021 - Monoclonal antibodies, a COVID-19 treatment given early after coronavirus infection, cut the risk of hospitalization and death by 60% in those most likely to suffer complications of the disease, according to an analysis of UPMC patients who received the medication compared to similar patients who did not.
UPMC and University of Pittsburgh School of Medicine physician-scientists published the findings today in Open Forum Infectious Diseases, a journal of the Infectious Diseases Society of America. The study involved bamlanivimab, a monoclonal antibody that is now offered only in combination with another monoclonal antibody to further increase its effectiveness a change mandated by the federal government after the study s completion. ....

United States , New York , National Institutes Of Health , Colleen Sullivan , Davidt Huang , Tina Khadem , Stephaniek Montgomery , Donaldm Yealy , Ryan Bariola , Derekc Angus , Oscarc Marroquin , Christopherw Seymour , Mary Kay Wisniewski , Kelsey Linstrum , Richardj Wadas , Mark Schmidhofer , Stephen Koscumb , Tami Minnier , Erin Mccreary , Allison Hydzik , Danielle Sampsell , Ghady Haidar , Graham Snyder , Kevin Collins , School Of Medicine , University Of Pittsburgh School Medicine ,